Patent Assignment
Reel/Frame 057142/0980
Release of Security Interest
Recorded: 2021-08-11
Pages: 7
Assignor
HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Executed: 2021-08-06
Assignee
ARBOR PHARMACEUTICALS, LLC
SIX CONCOURSE PARKWAY, SUITE 1800, ATLANTA, GEORGIA, 30328
Covered Properties
(27)
S-Nitrosothiols as Smooth Muscle Relaxants and Therapeutic Uses Thereof
Patent:
5,380,758 →
Application:
07/943,834 →
Treatment of Male Impotence with S-Nitrosylated Compounds
Patent:
5,648,393 →
Application:
08/297,698 →
Localized Use of Nitric Oxide-Adducts to Prevent Internal Tissue Damage
Patent:
6,255,277 →
Application:
08/438,418 →
Localized Use of Nitric Oxide-Adducts to Prevent Internal Tissue Damage
Patent:
6,087,479 →
Application:
08/460,465 →
Nitrosated and Nitrosylated Phosphodiesterase Inhibitor Compounds, Compositions and Their Uses
Patent:
5,958,926 →
Application:
09/145,142 →
Nitrosated and Nitrosylated Prostaglandins, Compositions and Methods of Use
Patent:
7,176,238 →
Application:
09/516,194 →
Localized Use of Nitric Oxide-Adducts to Prevent Internal Tissue Damage
Patent:
6,471,978 →
Application:
09/621,610 →
Methods of Treating and Preventing Congestive Heart Failure with Hydralazine Compounds and Isosorbide Dinitrate or Isosorbide Mononitrate
Patent:
6,465,463 →
Application:
09/658,261 →
Localized use of nitric oxide-adducts to prevent internal tissue damage
Patent:
6,352,709 →
Application:
09/661,190 →
Nitrosated and Nitrosylated Compouunds and Compositions and Their Use for Treating Respiratory Disorders
Patent:
6,579,863 →
Application:
09/689,851 →
Methods of Treating Vascular Diseases Characterized by Nitric Oxide Insufficiency
Patent:
6,635,273 →
Application:
09/697,317 →
Nitrosated and Nitrosylated Taxanes, Compositions and Methods of Use
Methods of Treating and Preventing Congestive Heart Failure with Hydralazine Compounds and Isosorbide Dinitrate or Isosorbide Mononitrate
Methods of Treating Vascular Diseases Characterized by Nitric Oxide Insufficiency
Nitrosated and Nitrosylated Compounds and Compositions and Their Use for Treating Respiratory Disorders
Methods for treating blood disorders with nitric oxide donor compounds
Application:
10/594,990 →
Publication:
US 2007/0191377
A Transdermal Patch Composition for Treating Vascular Diseases Characterized by Nitric Oxide Insufficiency
Composition For Treating Vascular Diseases Characterized By Nitric Oxide Insufficiency
Methods of Treating Vascular Diseases Characterized by Nitric Oxide Insufficiency
Nitrosated and Nitrosylated Compounds and Compositions and Their Use for Treating Respiratory Disorders
Nitrosated and Nitrosylated Prostaglandins, Compositions and Methods of Use
Compositions and Methods Using Apocynin Compounds and Nitric Oxide Donors
Furoxan Compounds, Compositions and Methods of Use
Methods Using Hydralazine Compounds and Isosorbide Dinitrate or Isosorbide Mononitrate
Application:
12/096,875 →
Publication:
US 2008/0293724
Nitrosated and Nitrosylated Prostaglandins, Compositions and Methods of Use
Solid Dosage Formulations of Hydralazine Compounds and Nitric Oxide Donor Compounds
Application:
12/300,593 →
Publication:
US 2009/0306081
Compositions for Treating Vascular Diseases Characterized by Nitric Oxide Insufficiency
Application:
12/564,550 →
Publication:
US 2010/0068267
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 25, 2013
From: NITROMED, INC.
To: ARBOR PHARMACEUTICALS, LLC
Reel/Frame 031281/0139 →
Assignment of Intellectual Property Security Agreement
Nov 15, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037112/0069 →
Security Interest
Jul 6, 2016
From: ARBOR PHARMACEUTICALS, LLC; XENOPORT, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 039266/0345 →
Security Interest
Sep 20, 2021
From: ARBOR PHARMACEUTICALS, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 057544/0803 →
Release of Security Interest
Oct 20, 2021
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ARBOR PHARMACEUTICALS, LLC; WILSHIRE PHARMACEUTICALS, INC.; XENOPORT, INC.
Reel/Frame 057880/0174 →
License
Nov 25, 2024
From: BRIGHAM AND WOMEN'S HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 069439/0134 →
Release of Security Interest
Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →